RADNOR, Pa., April 19, 2018 -- On April 19, 2018, Actua Corporation (OTCQB:ACTA) filed a Certificate of Dissolution with the State of Delaware in accordance with the Plan of Dissolution that was adopted by the Company’s Board of Directors on January 18, 2018 and approved by the Company’s stockholders on April 18, 2018. As of the close of business on April 19, 2018 (the “Effective Time”), the Company’s common stock will cease trading on the OTCQB Market and the Company’s transfer books will be closed. After the Effective Time, the Company will not record any further transfers of its common stock except transfers by will, intestate succession or operation of law and transfers initiated prior to the Effecitve Time, which will be allowed to settle even if those transfers would not settle until after the Effective Time. The Effective Time will also serve as the final record date for purposes of any future cash distributions to stockholders.
Following the Effective Time, the Company expects that it will no longer file Annual Reports on Form 10‑K or Quarterly Reports on Form 10‑Q, beginning with the Quarterly Report on Form 10-Q that the Company would otherwise file for the three months ended March 31, 2018. However, the Company will continue to disclose any material developments relating to the wind-down of its operations by filing Current Reports on Form 8-K until the time of its final liquidation.
Safe Harbor Statement under Private Securities Litigation Reform Act of 1995
The statements contained in this press release that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve certain risks and uncertainties, including, but not limited to, the valuation of our remaining non-cash assets by analysts, investors and other market participants, the effect of economic conditions generally, developments in the markets in which our remaining minority-held businesses operate, the impact of any potential acquisitions, dispositions or other strategic transactions (including in connection with the negotiation, execution and consummation thereof), our ability to manage capital resources effectively, our ability to monetize our remaining minority investments and otherwise execute on our plan of dissolution, and other risks and uncertainties detailed in Actua’s filings with the SEC. These and other factors may cause actual results to differ materially from those projected.
Investor inquiries:
Karen Greene
Actua
Investor Relations
610.727.6900
[email protected]


Trump Administration Plans New Drug Pricing Deals With Biotech Firms
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7%
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Yindjibarndi Appeals Fortescue Mining Compensation Ruling
Google Expands Gemini Enterprise With AI Tools for Legal Sector
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules
SK Hynix Shares Fall as Workers Reject Wage Deal
OpenAI AI Agent Swarm Behind Hugging Face Hack
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
Mercer International Stock Surges 45% on C$20 Million Canada Funding 



